Defining a national reference level for intraoperative radiation exposure in urological procedures: FLASH, a retrospective multicentre UK study.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 23 8 2019
medline: 7 7 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

To define reference levels for intraoperative radiation during stent insertion, ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL); to identify variation in radiation exposure between individual hospitals across the UK, between low- and high-volume PCNL centres, and between grade of lead surgeon. In all, 3651 patients were identified retrospectively across 12 UK hospitals over a 1-year period. Radiation exposure was defined in terms of total fluoroscopy time (FT) and dose area product (DAP). The 75th percentiles of median values for each hospital were used to define reference levels for each procedure. Reference levels: ureteric stent insertion/replacement (DAP, 2.3 Gy/cm This multicentre study is the largest of its kind. It provides the first national reference level to guide fluoroscopy use in urological procedures, thereby adding a quantitative and objective value to complement the principles of keeping radiation exposure 'as low as reasonably achievable'. This snapshot of real-time data shows significant variation around the country, as well as significant differences between low- and high-volume centres for PCNL, and grade of lead surgeon for stent procedures.

Identifiants

pubmed: 31437345
doi: 10.1111/bju.14903
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

292-298

Informations de copyright

© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Références

Linet MS, Slovis TL, Miller DL et al. Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin 2012; 62: 75-100
Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol 2017; 35: 1301-20
Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII - Phase 2. Washington DC: National Academies Press, 2006
Preston DL, Ron E, Tokuoka S et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 1-64
Ozasa K, Shimizu Y, Suyama A et al. Studies of the mortality of atomic bomb survivors, report 14. 1950-2003: an overview of cancer and noncancer diseases. Radiat Res 2012; 177: 229-43
Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate dose rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res 1995; 142: 295-304
Smith-Bindman R, Lipson J, Marcus R et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169: 2078-86
Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-84
Department of Health. The Ionising Radiation (Medical Exposure) Regulations 2017, Statutory Instrument No. 1075. London: The Stationery Office, 2017
International Commission on Radiological Protection (ICRP). The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007; 37: 1-332
Vañó E, Miller DL, Martin CJ et al. Publication 135: Diagnostic reference levels in medical imaging. Ann ICRP 2017; 46: 1-144
Hellawell GO, Mutch SJ, Thevendran G, Wells E, Morgan RJ. Radiation exposure and the urologist: what are the risks? J Urol 2005; 174: 948-52
Horsburgh BA, Higgins M. A study of occupational radiation dosimetry during fluoroscopically guided simulated urological surgery in the lithotomy position. J Endourol 2016; 30: 1312-20
Yang RM, Morgan T, Bellman GC. Radiation protection during percutaneous nephrolithotomy: a new urologic surgery radiation shield. J Endourol 2002; 16: 727-31
Christodoulou EG, Goodsitt MM, Larson SC, Darner KL, Satti J, Chan HP. Evaluation of the transmitted exposure through lead equivalent aprons used in a radiology department, including the contribution from backscatter. Med Phys 2003; 30: 1033-8
Hanna L, Walmsley BH, Devenish S, Rogers A, Keoghane SR. Limiting radiation exposure during percutaneous nephrolithotomy. J Endourol 2015; 29: 526-30
Jamal JE, Armenakas NA, Sosa RE, Fracchia JA. Perioperative patient radiation exposure in the endoscopic removal of upper urinary tract calculi. J Endourol 2011; 25: 1747-51
Martin J, Hennessey DB, Young M, Pahuja A. Radiographer delivered fluoroscopy reduces radiation exposure during endoscopic urological procedures. Ulster Med J 2016; 85: 8-12
World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-4
Watson SJ, Jones A, Oatway W, Hughes J. Ionising Radiation Exposure of the UK Population: 2005 Review. Chilton: Health Protection Agency, Centre for Radiation, Biochemical and Environmental Hazards, 2005.
Weld LR, Nwoye UO, Knight RB et al. Safety, minimization, and awareness radiation training reduces fluoroscopy time during unilateral ureteroscopy. Urology 2014; 84: 520-5
Ngo TC, Macleod LC, Rosenstein DI, Reese JH, Shinghai R. Tracking intraoperative fluoroscopy utilization reduces radiation exposure during ureteroscopy. J Endourol 2011; 25: 763-7
Blair B, Huang G, Arnold D et al. Reduced fluoroscopy protocol for percutaneous nephrolithotomy: feasibility, outcomes and effects on fluoroscopy time. J Urol 2013; 190: 2112-6
Chen TT, Wang C, Ferrandino MN et al. Radiation exposure during the evaluation and management of nephrolithiasis. J Urol 2015; 194: 878-85
Elkoushy MA, Shahrour W, Andonian S. Pulsed fluoroscopy in ureteroscopy and percutaneous nephrolithotomy. Urology 2012; 79: 1230-5
Lipkin ME, Mancini JG, Zilberman DE et al. Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol 2011; 25: 563-7
Khater N, Shen J, Arenas J et al. Bench-top feasibility testing of a novel percutaneous renal access technique: the laser Direct Alignment Radiation Reduction Technique (DARRT). J Endourol 2016; 30: 1155-60
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources, Effects and Risks of Atomic Radiation. UNSCEAR 2008 report to the General Assembly with Scientific Annexes. Volume 1. New York: United Nations, 2010
Weld LR, Nwoye UO, Knight RB et al. Fluoroscopy time during uncomplicated unilateral ureteroscopy for urolithiasis decreases with urology resident experience. World J Urol 2015; 33: 119-24
Kumar P. Radiation safety issues in fluoroscopy during percutaneous nephrolithotomy. Urol J 2008; 5: 15-23
Sourial MW, Todd AM, Palettas MS, Knudsen BE. Reducing fluoroscopy time in percutaneous nephrolithotomy. J Endourol 2019; 33: 369-74

Auteurs

Nick Simson (N)

Department of Urology, Guy's Hospital, London, UK.

Thomas Stonier (T)

King's College Hospital, London, UK.

Narin Suleyman (N)

Luton and Dunstable Hospital, Luton, UK.

Jane Hendry (J)

Queen Elizabeth Hospital, Glasgow, UK.

Miriam Salib (M)

Charing Cross Hospital, London, UK.

Julian Peacock (J)

Worthing Hospital, Worthing, UK.

Martin Connor (M)

North Middlesex Hospital, London, UK.

Oliver Jones (O)

Lister Hospital, Stevenage, UK.

James Schuster-Bruce (J)

Lister Hospital, Stevenage, UK.

Oliver Bottrell (O)

North Middlesex Hospital, London, UK.

Catherine Lovegrove (C)

West Middlesex Hospital, London, UK.

Louise English (L)

Worthing Hospital, Worthing, UK.

Heba Hamami (H)

Northwick Park Hospital, Harrow, UK.

Charles Horn (C)

Derriford Hospital, Plymouth, UK.

Joseph Bagley (J)

Bedford Hospital, Bedford, UK.

Abdurahman Bareh (A)

St George's Hospital, Cambridge, UK.

Dominic Jaikaransingh (D)

St George's Hospital, Cambridge, UK.

Nusrat Mohamed (N)

St George's Hospital, Cambridge, UK.

Uchenna Ukwu (U)

Cambridge University Hospitals, Cambridge, UK.

Nimlan Shanmugathas (N)

Guy's Hospital, London, UK.

Deepak Batura (D)

Northwick Park Hospital, Harrow, UK.

Jean McDonald (J)

West Middlesex Hospital, London, UK.

Konstantinos Charitopoulos (K)

North Middlesex Hospital, London, UK.

Alison Graham (A)

Charing Cross Hospital, London, UK.

Paimaun Zakikhani (P)

Worthing Hospital, Worthing, UK.

Sanjeev Taneja (S)

Luton and Dunstable Hospital, Luton, UK.

Henry Sells (H)

Derriford Hospital, Plymouth, UK.

Marco Bolgeri (M)

St George's Hospital, Cambridge, UK.

Oliver Wiseman (O)

Cambridge University Hospitals, Cambridge, UK.

John Bycroft (J)

Lister Hospital, Stevenage, UK.

Ahmed Qteishat (A)

Princess Alexandra Hospital, Harlow, UK.

Omar Aboumarzouk (O)

Queen Elizabeth Hospital, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH